What does CUSIP 803607AC4 represent in this 13F holders report?

CUSIP 803607AC4 is the security identifier for 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 used to aggregate holder disclosures.

How many institutions held 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in Q3 2022?

55 institutional investors reported 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 for Q3 2022. Use the holders table for investor-level position and value details.

SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1

CUSIP: 803607AC4

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Debt / DEBT 1.250% 9/1
Market price (% of par): 103.54%
Total 13F principal: $1,072,060,250
Principal change: +$1,072,060,250
Total reported market value: $1,111,296,466
Number of holders: 55
Value change: +$1,111,296,349
Number of buys: 55

Quarterly Holders Quick Answers

What is CUSIP 803607AC4?
CUSIP 803607AC4 identifies 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022

Recent filing periods for CUSIP 803607AC4:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

Institutional Holders of SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 as of Q3 2022

As of 30 Sep 2022, SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 was held by 55 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $1,072,060,250 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, Polar Asset Management Partners Inc., Voya Investment Management LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, CALAMOS ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Opti Capital Management, LP, and D. E. Shaw & Co., Inc.. This page lists 55 institutional bondholders reporting positions for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.